BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,124 filers reported holding BAXTER INTL INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $20,805,000 | -43.7% | 323,907 | -29.4% | 0.79% | -31.4% |
| Q2 2021 | $36,923,000 | -4.5% | 458,667 | +0.0% | 1.16% | -2.0% |
| Q1 2021 | $38,668,000 | +52.1% | 458,476 | +55.3% | 1.18% | -10.4% |
| Q2 2020 | $25,419,000 | +1.1% | 295,222 | -4.7% | 1.32% | -36.2% |
| Q1 2020 | $25,139,000 | -60.6% | 309,635 | -64.2% | 2.06% | +106.5% |
| Q2 2018 | $63,881,000 | -52.5% | 865,121 | -58.2% | 1.00% | -63.4% |
| Q1 2018 | $134,492,000 | +63.3% | 2,067,832 | +62.3% | 2.73% | +39.9% |
| Q4 2017 | $82,352,000 | -20.1% | 1,274,017 | -22.4% | 1.95% | -3.6% |
| Q3 2017 | $103,077,000 | +44.2% | 1,642,668 | +39.1% | 2.02% | +5.2% |
| Q2 2017 | $71,472,000 | +18.6% | 1,180,582 | +1.6% | 1.92% | +27.5% |
| Q1 2017 | $60,287,000 | -13.8% | 1,162,488 | -20.9% | 1.51% | -26.3% |
| Q3 2016 | $69,951,000 | +14.0% | 1,469,562 | +8.3% | 2.05% | +10.6% |
| Q2 2016 | $61,343,000 | – | 1,356,543 | – | 1.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |